[go: up one dir, main page]

AU2011904502A0 - Polypeptide constructs and uses thereof - Google Patents

Polypeptide constructs and uses thereof

Info

Publication number
AU2011904502A0
AU2011904502A0 AU2011904502A AU2011904502A AU2011904502A0 AU 2011904502 A0 AU2011904502 A0 AU 2011904502A0 AU 2011904502 A AU2011904502 A AU 2011904502A AU 2011904502 A AU2011904502 A AU 2011904502A AU 2011904502 A0 AU2011904502 A0 AU 2011904502A0
Authority
AU
Australia
Prior art keywords
polypeptide constructs
constructs
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2011904502A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceuticals Australia Pty Ltd
Original Assignee
Cephalon Australia Pty Ltd
Filing date
Publication date
Application filed by Cephalon Australia Pty Ltd filed Critical Cephalon Australia Pty Ltd
Publication of AU2011904502A0 publication Critical patent/AU2011904502A0/en
Priority to CN201810868213.4A priority Critical patent/CN109022465B/en
Priority to PCT/AU2012/001323 priority patent/WO2013059885A2/en
Priority to JP2014537430A priority patent/JP6184965B2/en
Priority to AU2012327877A priority patent/AU2012327877B2/en
Priority to NZ623812A priority patent/NZ623812B2/en
Priority to EP12843185.5A priority patent/EP3559049B1/en
Priority to SG11201401518TA priority patent/SG11201401518TA/en
Priority to EA201700111A priority patent/EA201700111A1/en
Priority to NZ734996A priority patent/NZ734996B2/en
Priority to NZ715807A priority patent/NZ715807B2/en
Priority to CN201280064672.8A priority patent/CN104203982B/en
Priority to KR1020197031072A priority patent/KR102096224B1/en
Priority to BR112014009925-1A priority patent/BR112014009925B1/en
Priority to MX2014005108A priority patent/MX360741B/en
Priority to CA2851892A priority patent/CA2851892C/en
Priority to ES12843185T priority patent/ES3033729T3/en
Priority to SG10201603411WA priority patent/SG10201603411WA/en
Priority to NZ756727A priority patent/NZ756727A/en
Priority to EA201400488A priority patent/EA034989B1/en
Priority to KR1020147014249A priority patent/KR102037541B1/en
Priority to ZA2014/02819A priority patent/ZA201402819B/en
Priority to IL232247A priority patent/IL232247B/en
Priority to US14/262,841 priority patent/US9611322B2/en
Priority to US15/194,926 priority patent/US20160367695A1/en
Priority to US15/447,912 priority patent/US10981986B2/en
Priority to JP2017144182A priority patent/JP2017193580A/en
Priority to AU2018200221A priority patent/AU2018200221B2/en
Priority to IL260045A priority patent/IL260045B/en
Priority to JP2019159406A priority patent/JP7111669B2/en
Abandoned legal-status Critical Current

Links

AU2011904502A 2011-10-28 2011-10-28 Polypeptide constructs and uses thereof Abandoned AU2011904502A0 (en)

Priority Applications (29)

Application Number Priority Date Filing Date Title
ES12843185T ES3033729T3 (en) 2011-10-28 2012-10-29 Polypeptide constructs and uses thereof
SG10201603411WA SG10201603411WA (en) 2011-10-28 2012-10-29 Polypeptide constructs and uses thereof
CA2851892A CA2851892C (en) 2011-10-28 2012-10-29 Polypeptide constructs and uses thereof
JP2014537430A JP6184965B2 (en) 2011-10-28 2012-10-29 Polypeptide constructs and uses thereof
AU2012327877A AU2012327877B2 (en) 2011-10-28 2012-10-29 Polypeptide constructs and uses thereof
NZ623812A NZ623812B2 (en) 2011-10-28 2012-10-29 Polypeptide constructs and uses thereof
EP12843185.5A EP3559049B1 (en) 2011-10-28 2012-10-29 Polypeptide constructs and uses thereof
SG11201401518TA SG11201401518TA (en) 2011-10-28 2012-10-29 Polypeptide constructs and uses thereof
EA201700111A EA201700111A1 (en) 2011-10-28 2012-10-29 POLYPEPTIDE STRUCTURES AND THEIR APPLICATION
NZ734996A NZ734996B2 (en) 2011-10-28 2012-10-29 Polypeptide constructs and uses thereof
NZ715807A NZ715807B2 (en) 2011-10-28 2012-10-29 Polypeptide constructs and uses thereof
CN201280064672.8A CN104203982B (en) 2011-10-28 2012-10-29 Polypeptide constructs and uses thereof
KR1020197031072A KR102096224B1 (en) 2011-10-28 2012-10-29 Polypeptide constructs and uses thereof
BR112014009925-1A BR112014009925B1 (en) 2011-10-28 2012-10-29 POLYPEPTIDE BUILDERS AND THEIR USES
MX2014005108A MX360741B (en) 2011-10-28 2012-10-29 Polypeptide constructs and uses thereof.
CN201810868213.4A CN109022465B (en) 2011-10-28 2012-10-29 Polypeptide constructs and their uses
KR1020147014249A KR102037541B1 (en) 2011-10-28 2012-10-29 Polypeptide constructs and uses thereof
PCT/AU2012/001323 WO2013059885A2 (en) 2011-10-28 2012-10-29 Polypeptide constructs and uses thereof
NZ756727A NZ756727A (en) 2011-10-28 2012-10-29 Polypeptide constructs and uses thereof
EA201400488A EA034989B1 (en) 2011-10-28 2012-10-29 POLYEPEPTIDE CONSTRUCTION FOR USE IN TREATMENT OF CANCER, INCLUDING ATTENUATED ALPHA-INTERFERON
ZA2014/02819A ZA201402819B (en) 2011-10-28 2014-04-16 Polypeptide constructs and uses thereof
IL232247A IL232247B (en) 2011-10-28 2014-04-24 Polypeptide structures and their uses
US14/262,841 US9611322B2 (en) 2011-10-28 2014-04-28 Fusions of antibodies to CD38 and attenuated interferon alpha
US15/194,926 US20160367695A1 (en) 2011-10-28 2016-06-28 Polypeptide constructs and uses thereof
US15/447,912 US10981986B2 (en) 2011-10-28 2017-03-02 Fusions of antibodies to CD38 and attenuated interferon alpha
JP2017144182A JP2017193580A (en) 2011-10-28 2017-07-26 Polypeptide construct and use thereof
AU2018200221A AU2018200221B2 (en) 2011-10-28 2018-01-11 Polypeptide constructs and uses thereof
IL260045A IL260045B (en) 2011-10-28 2018-06-14 Polypeptide constructs and uses thereof
JP2019159406A JP7111669B2 (en) 2011-10-28 2019-09-02 Polypeptide constructs and uses thereof

Publications (1)

Publication Number Publication Date
AU2011904502A0 true AU2011904502A0 (en) 2011-11-17

Family

ID=

Similar Documents

Publication Publication Date Title
IL260045B (en) Polypeptide constructs and uses thereof
EP2699590B8 (en) Endoglin polypeptides and uses thereof
IL222961A0 (en) Novel dna-dinding proteins and uses thereof
IL230918A0 (en) Modified proteins and peptides
WO2012149254A3 (en) Mfg-e8 and uses thereof
EP2565200A4 (en) Antifreeze protein
EP2892913A4 (en) Peptides and their uses
EP2698386B8 (en) Fusion protein
EP2580231A4 (en) Peptides, constructs and uses therefor
EP2670376A2 (en) Improved moisturiser blend
KR20180085063A (en) Novel protein material
EP2851083B8 (en) Radiation-sterilization-resistant protein composition
EP2673362A1 (en) B-type plexin antagonists and uses thereof
EP2891663B8 (en) Psf1-derived peptide
HK40017091A (en) Polypeptide constructs and uses thereof
EP2638160B8 (en) Nuclions and ribocapsids
AU2011904502A0 (en) Polypeptide constructs and uses thereof
HK1192893A (en) Modified proteins and peptides
AU2010905042A0 (en) Latrophilin-like protein
AU2011902431A0 (en) Fusion Proteins and Use Thereof
AU2013100947A4 (en) Surface Stabliser and Uses Thereof
HK1175998A (en) Peptides and their use
HK1188458A (en) Anti-sod1 antibodies and uses thereof
AU2011904284A0 (en) Novel protein
AU2011903104A0 (en) Composition And Uses Thereof